The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence

Sara Jansson(Lund University), Lisa Rydén(Lund University)

Breast Cancer Research and Treatment

January 29, 2018

10.1007/s10549-018-4664-7

Cited by 82

Related Papers

RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer

|npj Breast Cancer|2022|103

St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases - aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trial

|BMC Cancer|2013|74

Minimizing inequality in access to precision medicine in breast cancer by real-time population-based molecular analysis in the SCAN-B initiative

|British journal of surgery|2018|64

The Three Receptor Tyrosine Kinases c-KIT, VEGFR2 and PDGFRα, Closely Spaced at 4q12, Show Increased Protein Expression in Triple-Negative Breast Cancer

|PLoS ONE|2014|58

Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series

|Scientific Reports|2019|58